Be prepared for a lot more attention on the 340B program in the upcoming Congress, 340B Report Publisher and CEO Ted Slafsky predicts.
Be prepared for a lot more attention on the 340B program in the upcoming Congress, 340B Report Publisher and CEO [...] …
Novo Nordisk for the third time this year has announced refunds for 340B overcharges due to revisions of Medicaid pricing data.
Drug manufacturer Novo Nordisk for the third time this year has announced refunds for 340B overcharges due to revisions of [...] …
AIDS Healthcare Foundation (AHF) last week refiled its lawsuit against federally contracted 340B prime vendor Apexus
California-based AIDS Healthcare Foundation (AHF) last week refiled its lawsuit against Delaware-based federally contracted 340B prime vendor Apexus, setting forth [...] …
U.S. Reps. Robin Kelly (D-Ill.) and Brett Guthrie (R-Ky.) each said during an event yesterday they were hopeful Congress would act on 340B—Kelly regarding covered entities' concerns and Guthrie regarding those of payers and manufacturers.
The Democratic vice chair of the U.S. House Energy & Commerce Committee said during a media event yesterday she hopes [...] …
Lilly for the fifth time this year has announced refunds for overcharges on 340B-acquired drugs.
Drug manufacturer Eli Lilly for the fifth time this year has announced refunds for overcharges on 340B-acquired drugs. The latest [...] …
Lack of data makes it hard to assess 340B's impact on drug company launch prices and covered entities' uses of 340B savings, researchers at consulting firm Leavitt Partners say.
Lack of data makes it hard to assess the 340B program’s overall impact on drug prices charged by pharmaceutical companies [...] …
Novo Nordisk has decided to let 340B hospitals buy its drugs at a reduced 340B price for shipment to an unlimited number of contract pharmacies if the hospitals submit their claims data to 340B ESP.
Novo Nordisk on Jan.1 will implement a policy to let 340B hospitals buy its drugs at a reduced 340B price [...] …
An ad campaign by 340B hospital and pharmacy groups targets federal policymakers with messages touting the program's good deeds.
340B hospital and pharmacy groups have launched another digital ad campaign touting the 340B program’s benefits to policymakers. It comes [...] …
SPONSORED CONTENT Join Verity Solutions for our next Lunch & Learn webinar session on Thursday, December 15 at 1:30PM ET [...] …
RWC-340B is assessing how HRSA's proposed new 340B dispute resolution process would affect the group's ongoing dispute with AstraZeneca and ongoing lawsuit against HRSA and HHS.
Ryan White Clinics for 340B Access told a federal district judge last week it needs time to assess how proposed [...] …
*Sign up for news summaries and alerts from 340B Report
Copyright © 2025 340B Report, LLC
Reproduction of material from any 340B Report page without written permission is strictly prohibited.
